Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers The Lead Compound

Home › Targets › KCC2

KCC2 (1 companies · 2 programs)

Companies with an active program directed at KCC2.

Ovid Therapeutics Inc. OVID

OV4071 Phase 1
OV4071 Phase 1

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.